Similar articles

• Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin.

  Müller T, Sprenger H, Keuchel M, Neumann C, Ebel H, Gemsa D, Lange H. Müller T, et al. Transplant Proc. 1992 Dec;24(6):2636-8. Transplant Proc. 1992. PMID: 1334590 No abstract available.
• Low-dose OKT3 for cadaveric renal transplantation.

  Schweizer RT, Roper L, Hull D, Bartus SA. Schweizer RT, et al. Transplant Proc. 1992 Dec;24(6):2592-3. Transplant Proc. 1992. PMID: 1465875 No abstract available.
• Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.

  Morgan JD, Horsburgh T, Simpson A, Donnelly PK, Veitch PS, Bell PR. Morgan JD, et al. Transplant Proc. 1992 Dec;24(6):2634-5. Transplant Proc. 1992. PMID: 1334589 No abstract available.
• OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy).

  First MR, Schroeder TJ, Hariharan S. First MR, et al. Transplant Proc. 1993 Apr;25(2 Suppl 1):25-6. Transplant Proc. 1993. PMID: 8465417 Review. No abstract available.
• Sequential therapy in pediatric cadaveric renal transplantation: a critical analysis.

  Ettenger R, Marik J, Rosenthal JT. Ettenger R, et al. J Am Soc Nephrol. 1992 Jun;2(12 Suppl):S304-11. doi: 10.1681/ASN.V212s304. J Am Soc Nephrol. 1992. PMID: 1498290 Review.